Editing liver tumours

Gut

Volumn 63, Issue 5, 2014, Pages 709-710

  Colnot, Sabine ^a   Fortes, Puri ^b  

^a INSTITUT COCHIN   (France)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA; ADENOSINE DEAMINASE ACTING ON RNA 1; ADENOSINE DEAMINASE ACTING ON RNA 2; DOUBLE STRANDED RNA; INOSINE; UNCLASSIFIED DRUG;

ANTIZYME INHIBITOR 1 GENE; CANCER PROGNOSIS; COATOMER PROTEIN COMPLEX SUBUNIT ALPHA GENE; CONFORMATIONAL TRANSITION; FILAMIN B GENE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; NOTE; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE; PRIORITY JOURNAL; RNA EDITING; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; UTP14C GENE;

HEPATOCELLULAR CARCINOMA;

ADENOSINE DEAMINASE; ANIMALS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; RNA EDITING; RNA, DOUBLE-STRANDED; TUMOR MARKERS, BIOLOGICAL;

EID: 84897995676     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305334     Document Type: Note

References (10)

1. Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol 2013;10:34-42.
2. Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012;44:694-8.
3. Chan TH, Lin CH, Qi L, et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut 2014;63:832-43.
4. Chen L, Li Y, Lin CH, et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 2013;19:209-16.
5. Galeano F, Tomaselli S, Locatelli F, et al. A-to-I RNA editing: the "ADAR" side of human cancer. Semin Cell Dev Biol 2012;23:244-50.
6. Hartner JC, Schmittwolf C, Kispert A, et al. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004;279:4894-902. (Pubitemid 38199085)
7. Higuchi M, Maas S, Single FN, et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000;406:78-81. (Pubitemid 30460214)
8. Paz N, Levanon EY, Amariglio N, et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 2007;17:1586-95. (Pubitemid 350074854)
9. Nemlich Y, Greenberg E, Ortenberg R, et al. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest 2013 May 24. pii: 62980. doi: 10.1172/JCI62980. [Epub ahead of print].
10. Ota H, Sakurai M, Gupta R, et al. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 2013;153:575-89.